Intracranial hemorrhage mortality in atrial fibrillation patients treated with dabigatran or warfarin
about
Dabigatran-Associated Intracranial Hemorrhage: Literature Review and Institutional ExperienceSecondary stroke prevention: challenges and solutionsMisclassification in administrative claims data: quantifying the impact on treatment effect estimates.Traumatic fatal cerebral hemorrhage in an old patient with a history of multiple sclerosis under dabigatran: a case report and review of the literatureBleeding complications from the direct oral anticoagulants.Intracranial hemorrhage during administration of a novel oral anticoagulant.Minimizing the risk of hemorrhagic stroke during anticoagulant therapy for atrial fibrillation.Bleeding Risk, Management and Outcome in Patients Receiving Non-VKA Oral Anticoagulants (NOACs).Screening for atrial fibrillation in Canadian pharmacies: an economic evaluation.The Anticoagulated trauma patient in the age of the direct oral anticoagulants: a Canadian perspective.A post-marketing assessment of major bleeding in total hip and total knee replacement surgery patients receiving rivaroxaban.Association of Intracerebral Hemorrhage Among Patients Taking Non-Vitamin K Antagonist vs Vitamin K Antagonist Oral Anticoagulants With In-Hospital Mortality.Comparative effectiveness of novel oral anticoagulants in UK patients with non-valvular atrial fibrillation and chronic kidney disease: a matched cohort study.Incidence and characteristics of major bleeding among rivaroxaban users with renal disease and nonvalvular atrial fibrillation.Comparing intracerebral hemorrhages associated with direct oral anticoagulants or warfarin.
P2860
Q26783457-285856FB-91F3-41B2-A684-09ED4E451D54Q26795568-581083E0-613C-4771-B85F-616BB4F5B004Q30974376-681300DC-564E-448B-B1FB-C17A6F709DE1Q33165278-3182BA71-5EF1-443F-B14A-DEEB7DA33F8DQ35878677-985A5EB5-C514-4040-90F0-79B1133457D3Q37479416-FDB042D0-A4FB-44ED-94C9-32216EF5B47AQ38389058-2599693E-350A-4BD2-8C76-EBA4CBA54FC9Q38458642-78959267-2EDC-499B-AD99-A30913AC6EE2Q38611246-867B1D75-3A0C-49BD-816E-2BBBDBA09F65Q38646206-010513FC-444B-4849-8E85-D5FACDDFF51FQ47777774-AC5B8F4A-4A0A-4277-98AC-E80F018C3D6AQ47838584-3D68AEBA-C1E3-4AE8-9D8A-20927EBC5AA6Q49189865-1DAA111C-A816-42C0-8F34-CB6894B432B5Q55105150-5EB46826-ECC7-4612-8F17-9D0425E07605Q55342043-AA18A608-CA94-4556-9912-BF925EB4D1CD
P2860
Intracranial hemorrhage mortality in atrial fibrillation patients treated with dabigatran or warfarin
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Intracranial hemorrhage mortal ...... ed with dabigatran or warfarin
@ast
Intracranial hemorrhage mortal ...... ed with dabigatran or warfarin
@en
type
label
Intracranial hemorrhage mortal ...... ed with dabigatran or warfarin
@ast
Intracranial hemorrhage mortal ...... ed with dabigatran or warfarin
@en
prefLabel
Intracranial hemorrhage mortal ...... ed with dabigatran or warfarin
@ast
Intracranial hemorrhage mortal ...... ed with dabigatran or warfarin
@en
P2093
P2860
P1433
P1476
Intracranial hemorrhage mortal ...... ed with dabigatran or warfarin
@en
P2093
Kamakshi Lakshminarayan
Lindsay G S Bengtson
Pamela L Lutsey
Richard F MacLehose
P2860
P304
P356
10.1161/STROKEAHA.114.006016
P407
P577
2014-07-03T00:00:00Z